DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
Abstract High-grade serous ovarian cancer is the most common ovarian cancer type. Although the combination of surgery and platinum-taxane chemotherapy provide an effective treatment, drug resistance frequently occurs leading to poor outcome. In order to clarify the molecular mechanisms of drug resis...
Guardado en:
Autores principales: | Riikka J. Lund, Kaisa Huhtinen, Jussi Salmi, Juha Rantala, Elizabeth V. Nguyen, Robert Moulder, David R. Goodlett, Riitta Lahesmaa, Olli Carpén |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c01c760084d476eacca4d213f37d8c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.
por: Wei Yu, et al.
Publicado: (2011) -
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality
por: Joonas Jukonen, et al.
Publicado: (2021) -
Plasma cell-free DNA methylation marks for episodic memory impairment: a pilot twin study
por: M. Konki, et al.
Publicado: (2020) -
The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer.
por: Wei Wu, et al.
Publicado: (2014) -
Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
por: Christine S Walsh, et al.
Publicado: (2021)